In this episode of Mission Matters, host Adam Torres interviews David Berry, Managing Partner at Averin Capital, as part of the Asia Summit Series. David shares his experiences at the Milken Institute Asia Summit in Singapore, highlighting its value for networking and insightful conversations. He discusses Averin Capital's focus on the transformation of health through technology, emphasizing trends like AI, decentralization, and personalized care. David provides an example of BioLink, a company Averin Capital invested in, which is developing a new form of continuous glucose monitor using microneedles. He also shares what he looks for in founders and executive teams.
Sign in to continue reading, translating and more.
Continue